JPS6091989A - ストレプトコツカス属細菌による生理活性物質の生産方法 - Google Patents
ストレプトコツカス属細菌による生理活性物質の生産方法Info
- Publication number
- JPS6091989A JPS6091989A JP58199294A JP19929483A JPS6091989A JP S6091989 A JPS6091989 A JP S6091989A JP 58199294 A JP58199294 A JP 58199294A JP 19929483 A JP19929483 A JP 19929483A JP S6091989 A JPS6091989 A JP S6091989A
- Authority
- JP
- Japan
- Prior art keywords
- physiologically active
- active substance
- culture
- streptococcus
- medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013543 active substance Substances 0.000 title claims abstract description 31
- 241000194017 Streptococcus Species 0.000 title claims abstract description 22
- 241000894006 Bacteria Species 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title description 2
- 241000588724 Escherichia coli Species 0.000 claims abstract description 8
- 230000009036 growth inhibition Effects 0.000 claims abstract description 6
- 230000005764 inhibitory process Effects 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 230000000259 anti-tumor effect Effects 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 230000035699 permeability Effects 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000002609 medium Substances 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 230000001580 bacterial effect Effects 0.000 description 16
- 238000000034 method Methods 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 235000013372 meat Nutrition 0.000 description 8
- 238000000862 absorption spectrum Methods 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 229930182555 Penicillin Natural products 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 238000012258 culturing Methods 0.000 description 4
- 239000001963 growth medium Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229940049954 penicillin Drugs 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241000193996 Streptococcus pyogenes Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002523 gelfiltration Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000003068 static effect Effects 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 229940056360 penicillin g Drugs 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000005575 Cellulases Human genes 0.000 description 1
- 108010084185 Cellulases Proteins 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N Cysteine Chemical compound SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000007621 bhi medium Substances 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007376 cm-medium Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 125000004119 disulfanediyl group Chemical group *SS* 0.000 description 1
- 229940078469 dl- cysteine Drugs 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940076156 streptococcus pyogenes Drugs 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58199294A JPS6091989A (ja) | 1983-10-26 | 1983-10-26 | ストレプトコツカス属細菌による生理活性物質の生産方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP58199294A JPS6091989A (ja) | 1983-10-26 | 1983-10-26 | ストレプトコツカス属細菌による生理活性物質の生産方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6091989A true JPS6091989A (ja) | 1985-05-23 |
| JPS6326994B2 JPS6326994B2 (enrdf_load_stackoverflow) | 1988-06-01 |
Family
ID=16405410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58199294A Granted JPS6091989A (ja) | 1983-10-26 | 1983-10-26 | ストレプトコツカス属細菌による生理活性物質の生産方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6091989A (enrdf_load_stackoverflow) |
-
1983
- 1983-10-26 JP JP58199294A patent/JPS6091989A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6326994B2 (enrdf_load_stackoverflow) | 1988-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2787446B2 (ja) | Ａｂ−００６抗生物質及びその製造方法 | |
| JPH02288889A (ja) | Ａｂ‐０２１抗生物質およびその製造法 | |
| JPS6091989A (ja) | ストレプトコツカス属細菌による生理活性物質の生産方法 | |
| US4016260A (en) | Novel polypeptide produced by pseudomonas | |
| JPS5948992B2 (ja) | 抗生物質ｃ−１４４８２ａ↓１ | |
| US3089816A (en) | Lemacidine and process for its manufacture | |
| JP2839032B2 (ja) | Ａｂ―０１１抗生物質およびその製造法 | |
| US3297526A (en) | Process for producing coprogen and desferricoprogen | |
| JPS6092218A (ja) | 抗腫瘍性物質の製造法 | |
| JPS6030677A (ja) | ストレプトコツカス属細菌の培養法 | |
| JPS60218324A (ja) | 生理活性物質ｓｐｆ−２及びその製法 | |
| KR790001610B1 (ko) | 항생물질 mm 13902의 제조방법 | |
| JPH04104795A (ja) | 新規物質ｓｂｓ及びその製造方法 | |
| Uchida et al. | METABOLIC PRODUCTS OF MICROORGANISMS 137 RINAMYCIN, A NEW INHIBITOR OF RNA SYNTHESIS | |
| JPS6030689A (ja) | 生理活性物質ｓｐｆ−１及びその製法 | |
| JPH0155276B2 (enrdf_load_stackoverflow) | ||
| JPS61141895A (ja) | 核酸系物質を構成成分として含有する新規な核酸系高分子物質及びその製造法 | |
| JPS6287521A (ja) | 抗腫瘍性物質ｓｐｆ−１００−ｆ２及びその製法 | |
| JPS62135497A (ja) | Ｐ４物質及びその製造法 | |
| JPH0156076B2 (enrdf_load_stackoverflow) | ||
| WALTER | ISOLATION AND CHARACTERIZATION OF A PEPTIDE ANTIBIOTIC SYNTHESIZED BY MUCOR PUSILLUS. | |
| Polson et al. | A brain factor influencing the viability of neurotropic Rift Valley fever | |
| JPH0156075B2 (enrdf_load_stackoverflow) | ||
| JPS5828293A (ja) | マイトマイシン類の製造法 | |
| JPH0571232B2 (enrdf_load_stackoverflow) |